Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $128.8 million.

  • Acadia Healthcare Company's Cost of Revenue rose 1484.79% to $128.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.1 million, marking a year-over-year increase of 1759.66%. This contributed to the annual value of $440.8 million for FY2024, which is 1334.05% up from last year.
  • Per Acadia Healthcare Company's latest filing, its Cost of Revenue stood at $128.8 million for Q3 2025, which was up 1484.79% from $134.4 million recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Cost of Revenue registered a high of $134.4 million during Q2 2025, and its lowest value of $72.0 million during Q1 2021.
  • Moreover, its 5-year median value for Cost of Revenue was $95.9 million (2023), whereas its average is $97.8 million.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 3238.47% in 2021, then soared by 445.69% in 2023.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Cost of Revenue stood at $79.1 million in 2021, then grew by 18.77% to $93.9 million in 2022, then increased by 4.46% to $98.1 million in 2023, then rose by 20.16% to $117.9 million in 2024, then rose by 9.25% to $128.8 million in 2025.
  • Its Cost of Revenue was $128.8 million in Q3 2025, compared to $134.4 million in Q2 2025 and $114.0 million in Q1 2025.